SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 8-K - Current report:
SEC Accession No. 0001493152-20-019566
Filing Date
2020-10-16
Accepted
2020-10-16 16:15:16
Documents
13
Period of Report
2020-10-09
Items
Item 1.01: Entry into a Material Definitive Agreement
Item 5.02: Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers: Compensatory Arrangements of Certain Officers
Item 9.01: Financial Statements and Exhibits

Document Format Files

Seq Description Document Type Size
1 form8-k.htm   iXBRL 8-K 36032
2 ex10-1.htm EX-10.1 103093
  Complete submission text file 0001493152-20-019566.txt   335947

Data Files

Seq Description Document Type Size
3 XBRL SCHEMA FILE abeo-20201009.xsd EX-101.SCH 3216
4 XBRL LABEL FILE abeo-20201009_lab.xml EX-101.LAB 34591
5 XBRL PRESENTATION FILE abeo-20201009_pre.xml EX-101.PRE 22730
6 EXTRACTED XBRL INSTANCE DOCUMENT form8-k_htm.xml XML 3615
Mailing Address 1330 AVENUE OF THE AMERICAS, 33RD FLOOR NEW YORK NY 10019
Business Address 1330 AVENUE OF THE AMERICAS, 33RD FLOOR NEW YORK NY 10019 646-813-4701
ABEONA THERAPEUTICS INC. (Filer) CIK: 0000318306 (see all company filings)

IRS No.: 830221517 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 8-K | Act: 34 | File No.: 001-15771 | Film No.: 201244202
SIC: 2834 Pharmaceutical Preparations